Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

High resolution analysis of functional determinants on human tissue-type plasminogen activator.

Bennett WF, Paoni NF, Keyt BA, Botstein D, Jones AJ, Presta L, Wurm FM, Zoller MJ.

J Biol Chem. 1991 Mar 15;266(8):5191-201.

2.

Kringle glycosylation in a modified human tissue plasminogen activator improves functional properties.

Berg DT, Burck PJ, Berg DH, Grinnell BW.

Blood. 1993 Mar 1;81(5):1312-22.

3.

Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.

Bakker AH, Nieuwenbroek NM, Verheijen JH.

Protein Eng. 1995 Dec;8(12):1295-1302.

PMID:
8869642
4.

Tissue-type plasminogen activator mutants imitating urokinase in the peptide link between kringle and protease domains and at selected sites within the protease domain.

Hinzmann B, Wernicke D, Pfeifer M, Zacharias U, Fischer B, Eisenmenger F, Will H.

Eur J Biochem. 1993 Apr 1;213(1):437-43.

6.

Involvement of finger domain and kringle 2 domain of tissue-type plasminogen activator in fibrin binding and stimulation of activity by fibrin.

Verheijen JH, Caspers MP, Chang GT, de Munk GA, Pouwels PH, Enger-Valk BE.

EMBO J. 1986 Dec 20;5(13):3525-30.

7.
8.

Tissue-type plasminogen activator variants with domain duplications and rearrangements.

Markland W, Pollock D, Livingston DJ.

Protein Eng. 1989 Nov;3(2):111-6.

PMID:
2556697
11.

Introduction of lysine and clot binding properties in the kringle one domain of tissue-type plasminogen activator.

Bakker AH, van der Greef W, Rehberg EF, Marotti KR, Verheijen JH.

J Biol Chem. 1993 Sep 5;268(25):18496-501.

12.

Biochemical and functional characterization of human tissue-type plasminogen activator variants with mutagenized kringle domains.

Collen D, Lijnen HR, Bulens F, Vandamme AM, Tulinsky A, Nelles L.

J Biol Chem. 1990 Jul 25;265(21):12184-91.

14.

Making tissue-type plasminogen activator more fibrin specific.

Paoni NF, Chow AM, Peña LC, Keyt BA, Zoller MJ, Bennett WF.

Protein Eng. 1993 Jul;6(5):529-34.

PMID:
8415579
16.
17.

Hybrid molecules: insights into plasminogen activator function.

Runge MS, Bode C, Haber E, Quertermous T.

Mol Biol Med. 1991 Apr;8(2):245-55. Review.

PMID:
1806766
18.

Variants of human tissue-type plasminogen activator substituted at the protease cleavage site and glycosylation sites, and truncated at the N- and C-termini.

Haigwood NL, Mullenbach GT, Moore GK, DesJardin LE, Tabrizi A, Brown-Shimer SL, Stauss H, Stöhr HA, Pâques EP.

Protein Eng. 1989 Aug;2(8):611-20.

PMID:
2510149
19.

Functional properties of the recombinant kringle-2 domain of tissue plasminogen activator produced in Escherichia coli.

Wilhelm OG, Jaskunas SR, Vlahos CJ, Bang NU.

J Biol Chem. 1990 Aug 25;265(24):14606-11.

20.
Items per page

Supplemental Content

Write to the Help Desk